ASCCP GUIDELINES 2013 PDF

The primary objective was to determine the theoretical number of colposcopies at a resident clinic if the American Society for Colposcopy and Cervical Pathology ASCCP guidelines were applied. The secondary objective was to determine the actual number of colposcopies before and after the ASCCP guidelines. This was a two-part descriptive study. The first part applied the ASCCP guidelines to all pre-guideline colposcopy cases at a single resident clinic. These theoretical results were then compared to the actual number of colposcopies. The second part compared the actual number of colposcopies during the one-year time period before and after the guidelines.

Author:Yorisar Goktilar
Country:Philippines
Language:English (Spanish)
Genre:Software
Published (Last):13 December 2005
Pages:330
PDF File Size:17.57 Mb
ePub File Size:2.25 Mb
ISBN:221-3-30731-854-1
Downloads:46943
Price:Free* [*Free Regsitration Required]
Uploader:Turn



A group of 47 experts representing 23 professional societies, national and international health organizations, and federal agencies met in Bethesda, MD, September , , to revise the American Society for Colposcopy and Cervical Pathology Consensus Guidelines. The group's goal was to provide revised evidence-based consensus guidelines for managing women with abnormal cervical cancer screening tests, cervical intraepithelial neoplasia CIN and adenocarcinoma in situ AIS following adoption of cervical cancer screening guidelines incorporating longer screening intervals and co-testing.

In addition to literature review, data from almost 1. Where data were available, guidelines prescribed similar management for women with similar risks for CIN 3, AIS, and cancer.

Most prior guidelines were reaffirmed. Examples of updates include: Human papillomavirus-negative atypical squamous cells of undetermined significance results are followed with co-testing at 3 years before return to routine screening and are not sufficient for exiting women from screening at age 65 years; women aged years need less invasive management, especially for minor abnormalities; postcolposcopy management strategies incorporate co-testing; endocervical sampling reported as CIN 1 should be managed as CIN 1; unsatisfactory cytology should be repeated in most circumstances, even when HPV results from co-testing are known, while most cases of negative cytology with absent or insufficient endocervical cells or transformation zone component can be managed without intensive follow-up.

This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. Search: Search. Advanced Clipboard. Create file Cancel. Email citation To:. Format: Summary Summary text Abstract Abstract text.

Send email Cancel. Add to Collections Create a new collection Add to an existing collection. Name your collection: Name must be less than characters.

Choose a collection: Unable to load your collection due to an error Please try again. Add Cancel. Add to My Bibliography My Bibliography. Unable to load your delegates due to an error Please try again. Your saved search Name of saved search:. Search terms:. Test search terms. Would you like email updates of new search results? Email: change. Frequency: Monthly Weekly Daily. Which day? Send at most: 1 item 5 items 10 items 20 items 50 items items items.

Send even when there aren't any new results. Optional text in email:. Save Cancel. Create a file for external citation management software Create file Cancel. Full-text links Cite Favorites. Abstract A group of 47 experts representing 23 professional societies, national and international health organizations, and federal agencies met in Bethesda, MD, September , , to revise the American Society for Colposcopy and Cervical Pathology Consensus Guidelines.

Similar articles updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Massad LS, et al. Obstet Gynecol.

PMID: The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors. Cox JT, et al.

Arch Pathol Lab Med. Wright TC Jr, et al. J Low Genit Tract Dis. Am J Obstet Gynecol. PMID: Review. Show more similar articles See all similar articles. Cited by articles The role of human papillomavirus genotyping for detecting high-grade intraepithelial neoplasia or cancer in HPV-positive women with normal cytology: a study from a hospital in northeastern China.

Zhang J, et al. BMC Cancer. Egemen D, et al. Cheung LC, et al. Schiffman M, et al. No abstract available. Abdulaziz AMA, et al. Int J Clin Exp Pathol. Show more "Cited by" articles See all "Cited by" articles. Publication types Practice Guideline Actions. Female Actions. Humans Actions. Practice Guidelines as Topic Actions. Full-text links [x] Wolters Kluwer. Copy Download.

FW LINUXVPN PDF

Management of Abnormal Cervical Cancer Screening Test Results and Cervical Cancer Precursors

A group of 47 experts representing 23 professional societies, national and international health organizations, and federal agencies met in Bethesda, MD, September , , to revise the American Society for Colposcopy and Cervical Pathology Consensus Guidelines. The group's goal was to provide revised evidence-based consensus guidelines for managing women with abnormal cervical cancer screening tests, cervical intraepithelial neoplasia CIN and adenocarcinoma in situ AIS following adoption of cervical cancer screening guidelines incorporating longer screening intervals and co-testing. In addition to literature review, data from almost 1. Where data were available, guidelines prescribed similar management for women with similar risks for CIN 3, AIS, and cancer. Most prior guidelines were reaffirmed.

LOEWE PRIJSLIJST 2011 PDF

Guidelines

Read terms. Guidelines have been revised several times over the past decade to incorporate new evidence and technologies 1 2. Important changes to these guidelines include the following: Defining when to return to routine screening after treatment or resolution of abnormalities given the longer screening intervals recommended by the updated American Cancer Society screening guidelines 4. The purpose of this document is to present the most recent revisions to guidelines for managing abnormal cervical cancer screening test results and cervical cancer precursors, describe the LAST Project terminology, and provide guidance on applying the new management guidelines with this terminology. ACOG Clinical is designed for easy and convenient access to the latest clinical guidance for patient care. Figure 1.

Related Articles